Dr. Olusegun Apata, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 650 Grant St Ste 7, Gary, IN 46404 Phone: 219-882-9900 |
Raied Abdullah, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3229 Broadway, Suite 205, Gary, IN 46409 Phone: 219-887-4950 Fax: 219-887-4955 |
Kupusamy Umapathy, M.D. Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 4802 Broadway, Gary, IN 46408 Phone: 219-887-4950 |
Dr. Mark Alan Washington, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Grant St, Gary, IN 46402 Phone: 121-988-6400 |
News Archive
Big W stores in Australia have apologized after selling inflammable children's night wear labeled as "low fire danger". Australian Competition and Consumer Commission (ACCC) deputy chair Peter Kell said in a statement, "The ACCC enforces a mandatory standard for the labelling of children's nightwear," "It is designed to reduce the risk of burns injuries to children by providing specific information on the fire hazard," he said. "There is considerable research which shows that clear labelling helps minimise the risk of these injuries, which is why the ACCC regularly monitors compliance."
The majority of preschoolers may not be getting the amount of sleep they need each night, placing them at higher risk of being overweight or obese within a year, according to a new study.
A new, $500,000 instrument recently went about its work emitting and reading high-speed pulses of silent and invisible terahertz rays.
The Center for Law and the Public's Health at Georgetown and Johns Hopkins Universities has been designated a World Health Organization (WHO) and Pan American Health Organization (PAHO) Collaborating Center on Public Health Law and Human Rights , making it the only academic center of its kind to receive this global status.
The number of orphan product designations in the U.S. more than doubled during the last decade, reflecting growing interest by pharmaceutical and biotech companies in developing products to treat orphan diseases, according to a study recently completed by the Tufts Center for the Study of Drug Development.
› Verified 4 days ago